Citation Impact
Citing Papers
A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery
2019
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
2009
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
2013
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
2014
Tumor Immunoediting by NKp46
2010
Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function
2008
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
2012
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Combining immunotherapy and targeted therapies in cancer treatment
2012
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Global patterns and trends in the incidence of non-Hodgkin lymphoma
2019
NK cells and cancer immunosurveillance
2008
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
2020
Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
2013
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
Immunosurveillance and immunotherapy of tumors by innate immune cells
2015
Genetically engineered T cells for cancer immunotherapy
2019
The Science of Antibiotic Discovery
2020 Standout
Membrane vesicles as conveyors of immune responses
2009 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
2009
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Considerations for diagnostic COVID-19 tests
2020
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Microenvironmental regulation of metastasis
2008 Standout
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
2020
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis
2018
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
2020
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
2020
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
But Economics Is Not an Experimental Science
2010 StandoutNobel
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma
2014
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Natural killer cells: role in local tumor growth and metastasis
2012
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Cytokine Storm
2020 Standout
Rapid and Sensitive Detection of Antigen from SARS-CoV-2 Variants of Concern by a Multivalent Minibinder-Functionalized Nanomechanical Sensor
2022 StandoutNobel
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2020 Standout
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
2020
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn
2024 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
2008
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Coronavirus Infections—More Than Just the Common Cold
2020 Standout
Noncovalent Interaction Analysis in Fluctuating Environments
2013
Immunogenic Cell Death in Cancer Therapy
2012 Standout
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
2020 Standout
Works of Boris Böll being referenced
Role of [18F]-fluoro-2-deoxy-d -glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone
2011
Cytokine release syndrome
2018
Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells
2007
Letalität hämatoonkologischer Patienten in Neutropenie auf der Intensivstation
2015
TNF-α-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species
2009
Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-κB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell–Mediated Cytotoxicity
2009
COVID‐19 associated pulmonary aspergillosis
2020
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
2011
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group
2014